Lantheus Holdings (LNTH) Amortization of Deferred Charges (2016 - 2026)
Lantheus Holdings' (LNTH) quarterly Amortization of Deferred Charges came in at $1.1 million in Q1 2026, little changed year-on-year from $1.1 million in Q1 2025, and little changed on a QoQ basis from $1.1 million in Q4 2025.
Lantheus Holdings (LNTH) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 11 years of Amortization of Deferred Charges data on file, last reported at $1.1 million in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges changed 0.0% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a 2.74% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 3.75% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $1.1 million, roughly flat from $1.1 million in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for LNTH reached as high as $1.1 million in Q1 2025 and fell as low as $245000.0 in Q2 2022.
- Historically, Amortization of Deferred Charges has averaged $906882.4 across 5 years, with a median of $1.1 million in 2023.
- Across the five-year window, Amortization of Deferred Charges surged 503.28% in 2022 and declined 0.83% in 2024, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $512000.0 in 2022, then surged by 109.57% to $1.1 million in 2023, then rose by 0.56% to $1.1 million in 2024, then rose by 3.24% to $1.1 million in 2025, then climbed by 0.09% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.07 Mn |
| Dec 31, 2023 | 1.07 Mn |